Citations

Mayo Clinic

Showing 10 of 108572 citations.

IDENTIFICATION OF CHOROIDAL VASCULAR ABNORMALITIES IN PATIENTS WITH HEREDITARY HEMORRHAGIC TELANGIECTASIA
Luong, Hanna N. , Houghton, Odette M.

RETINAL Cases & Brief Reports | December 13, 2023 | Volume: 19 | Issue: 2 | Pages: 232-235

10.1097/icb.0000000000001532 | PMID 38091604 Get It

Purpose: The aim of this study was to evaluate the frequency of ocular imaging in patients with hereditary hemorrhagic telangiectasia (HHT) at a large academic medical institution, characterize the choroidal vascular changes on indocyanine green angiography and optical coherence tomography, and explore the relationship of these ocular features with HHT genotypes and systemic manifestations. Methods: This is a retrospective review of patients with HHT who were seen in the Mayo Clinic ophthalmology department between 2011 and 2021. Results: Of the 71 patients with HHT identified, 7 patients (10%) had qualifying imaging defined as radial or raster spectral-domain optical coherence tomography scans and/or indocyanine green angiography. Four patients (57%) had enlarged choroidal vessels detected on optical coherence tomography and/or indocyanine green angiography. Three patients (43%) had retinal telangiectasias. Patients with choroidal changes (mean age 67 years) had the endoglin gene mutation, gastrointestinal arteriovenous malformations, and facial and mucocutaneous telangiectasias. By contrast, patients without choroidal changes (mean age 45 years) included the activin A receptor-like kinase 1 gene mutation. Conclusion: Only a small proportion of patients with HHT undergo ophthalmic imaging at the authors’ institution. The presence of choroidal abnormalities is associated with the endoglin gene mutation, older age, corroborating retinal vascular changes, and increased systemic manifestations.
Combat strategies for charge sharing and pulse pileup with photon counting detectors
Iwanczyk, Jan S., Hsieh, S. S., Taguchi, Katsuyuki , Hsieh, S. S.

2023 IEEE Nuclear Science Symposium, Medical Imaging Conference and International Symposium on Room-Temperature Semiconductor De | December 13, 2023 | Volume: No volume available | Issue: No issue available | Pages: 1-1

10.1109/nssmicrtsd49126.2023.10338451 Get It

Strategies to improve the detective quantum efficiency of silicon photon counting detectors
Hsieh, Shuchen , Taguchi, Katsuyuki , Hsieh, S. S.

2023 IEEE Nuclear Science Symposium, Medical Imaging Conference and International Symposium on Room-Temperature Semiconductor De | December 13, 2023 | Volume: No volume available | Issue: No issue available | Pages: 1-1

10.1109/nssmicrtsd49126.2023.10337816 Get It

Improving R0 Resection Rates With a Posterior-First, 2-Stage Approach for En Bloc Resection of Locally Advanced Primary and Recurrent Anorectal Cancers Involving the Deep Pelvic Sidewall
Karim, S. Mohammed, Martinez‐Jorge, Jorys, Mathis, Kellie L. , Rose, Peter S. , Dozois, Eric J. , Sakata, Shinichiro , Martinez-Jorge, Jorys, Kelley, Scott R. , Dozois, Eric J , Larson, David W.

Diseases of the Colon & Rectum | December 13, 2023 | Volume: 67 | Issue: 1 | Pages: 90-96

10.1097/dcr.0000000000003035 | PMID 38091415 Get It

BACKGROUND: Using standard anterior approaches, consistent R0 resection of locally advanced primary and recurrent rectal and anal cancer involving the deep pelvic sidewall may be unattainable. Therefore, to improve R0 resection rates, we have used a posterior-first, then anterior 2-stage approach to resection of tumors in this location. OBJECTIVE: To assess the R0 resection rate and surgical outcomes of the first 10 patients operated on using this approach. DESIGN: We conducted a retrospective case series review of our prospectively maintained surgical pathology and tumor registries. SETTING: This study was conducted at the Mayo Clinic in Rochester, Minnesota. PATIENTS: Ten patients (6 female individuals, median age 53.5 years) with primary or recurrent anal or rectal cancer treated with a posterior-first, then anterior 2-stage approach were identified. MAIN OUTCOME MEASURES: The primary outcome measures were the R0 resection rate and surgical outcomes. RESULTS: An R0 resection was achieved in all 10 patients. Nine patients developed 1 or more 30-day Clavien-Dindo grade III complications. Nine patients developed gluteal wound complications ranging from superficial wound dehiscence to flap necrosis. During the follow-up period, 4 patients were found to have metastatic disease and 1 patient had local re-recurrence. LIMITATIONS: Small cohort with heterogeneous tumors and a short follow-up duration. CONCLUSION: A posterior-first, then anterior 2-stage approach has allowed us to achieve consistent R0 resection margins in locally advanced primary and recurrent rectal and anal cancers involving the deep pelvic sidewall. Poor wound healing of the posterior gluteal incision is a common complication. See Video Abstract. MEJORANDO LAS TASAS DE RESECCIÓN R0 CON UN ABORDAJE DE DOS ETAPAS PRIMERO POSTERIOR PARA LA RESECCIÓN EN BLOQUE DE CÁNCERES ANORRECTALES PRIMARIOS Y RECURRENTES LOCALMENTE AVANZADOS QUE AFECTAN LA PARED LATERAL PÉLVICA PROFUNDA ANTECEDENTES: Utilizando abordajes anteriores estándares, la resección R0 consistente del cáncer de recto y ano primario y recurrente localmente avanzado involucrando la pared lateral pélvica profunda puede ser inalcanzable. Por lo tanto, para mejorar las tasas de resección R0, hemos empleado un abordaje de 2 etapas primero posterior y luego anterior para la resección de tumores en esta ubicación. OBJETIVO: Este estudio tuvo como objetivo evaluar la tasa de resección R0 y los resultados quirúrgicos de los primeros 10 pacientes operados con este abordaje. DISEÑO: Realizamos una revisión retrospectiva de series de casos de nuestros registros de patología quirúrgica y tumores mantenidos prospectivamente. AJUSTE: Este estudio se realizó en la Clínica Mayo en Rochester, Minnesota, EE. UU. PACIENTES: Se identificaron diez pacientes (6 mujeres, mediana de edad 53.5 años) con cáncer anal o rectal primario o recurrente tratados con un abordaje de dos etapas, primero posterior y luego anterior. PRINCIPALES MEDIDAS DE RESULTADO: Las medidas de resultado primarias fueron la tasa de resección R0 y los resultados quirúrgicos. RESULTADOS: Se logró una resección R0 en los 10 pacientes. Nueve pacientes desarrollaron una o más complicaciones de grado III de Clavien-Dindo a los 30 días. Nueve pacientes desarrollaron complicaciones de la herida del glúteo que variaron desde dehiscencia superficial de la herida hasta necrosis del colgajo. Durante el período de seguimiento, se encontró que 4 pacientes tenían enfermedad metastásica y un paciente tuvo recurrencia local. LIMITACIONES: Cohorte pequeño con tumores heterogéneos y corta duración de seguimiento. CONCLUSIÓN: Un abordaje en 2 etapas, primero posterior y luego anterior, nos ha permitido lograr márgenes de resección R0 consistentes en cánceres de recto y anal primarios y recurrentes localmente avanzados que afectan la pared lateral pélvica profunda. La mala cicatrización de la incisión glútea posterior es una complicación común. (Traducción—Dr. Aurian Garcia Gonzalez)
Race‐ethnicity and sex differences in 1‐year survival following percutaneous coronary intervention among Medicare fee‐for‐service beneficiaries
Falk, Kristine, Grove, Lexie R. , Rossi, Joseph S. , Savitz, Samuel T. , Stearns, Sally C. , Pathman, Donald E.

Journal of Evaluation in Clinical Practice | December 13, 2023 | Volume: 30 | Issue: 3 | Pages: 406-417

10.1111/jep.13954 | PMID 38091249 Get It

AbstractRationaleExisting literature describing differences in survival following percutaneous coronary intervention (PCI) by patient sex, race‐ethnicity and the role of socioeconomic characteristics (SEC) is limited.Aims and ObjectivesEvaluate differences in 1‐year survival after PCI by sex and race‐ethnicity, and explore the contribution of SEC to observed differences.MethodsUsing a 20% sample of Medicare claims data for beneficiaries aged 65+, we identified fee‐for‐service patients who received PCI from 2007 to 2015. We performed logistic regression to assess how sex and race‐ethnicity relate to procedural indication, inpatient versus outpatient setting, and 1‐year mortality. We evaluated whether these relationships are moderated by sequentially controlling for factors including age, comorbidities, presence of acute myocardial infarction (AMI), county SEC, medical resource availability and inpatient versus outpatient procedural status.ResultsWe identified 300,491 PCI procedures, of which 94,863 (31.6%) were outpatient. There was a significant transition to outpatient PCI during the study period, especially for men compared with women and White patients compared with Black patients. Black patients were 3.50 percentage points (p < 0.001) and women were 3.41 percentage points (p < 0.001) more likely than White and male patients to undergo PCI at the time of AMI, which typically occurs in the inpatient setting. Controlling for age and calendar year, Black patients were 2.87 percentage points more likely than non‐Hispanic White patients to die within 1 year after PCI. After controlling for Black–White differences in comorbidities, the differences in 1‐year mortality decreased to 0.95 percentage points, which then became nonsignificant when further controlling for county resources and state of residence.ConclusionWomen were more likely to experience PCI in the setting of AMI and had less transition to outpatient care during the period. Black patients experienced higher 1‐year mortality following PCI, which is explained by differences in baseline comorbidities, county medical resources, and state of residence.
Association of COVID-19 Intensity With Burnout and Perceptions of Residency Preparedness Among Medical Students
Brushaber, Danielle , Dyrbye, Liselotte N. , West, Colin P.

JAMA Network Open | December 13, 2023 | Volume: 6 | Issue: 12 | Pages: e2347957

10.1001/jamanetworkopen.2023.47957 | PMID 38091043 Get It

This cross-sectional study of US medical students assesses the association of COVID-19 intensity in the clinical learning environment with student burnout and perceptions regarding residency preparedness.
ChatGPT hallucinating: can it get any more humanlike?
Siontis, Konstantinos C. , Asirvatham, Samuel J. , Friedman, Paul A. , Friedman, Paul A , Asirvatham, Samuel J , Attia, Zachi I.

European Heart Journal | December 13, 2023 | Volume: 45 | Issue: 5 | Pages: 321-323

10.1093/eurheartj/ehad766 | PMID 38088452 Get It

Defining an approach for therapeutic strategies in metabolic dysfunction–associated steatotic liver disease after liver transplantation
Siddiqui, Mohammad Shadab , Satapathy, Sanjaya K. , Patidar, Kavish R. , Watt, Kymberly D. , Rinella, Mary E. , Sathapathy, Sanjaya , Rinella, Mary , Patidar, Kavish R , Muthiah, Mark D , Bhat, Mamatha , Brandman, Danielle

Hepatology | December 13, 2023 | Volume: 82 | Issue: 3 | Pages: 766-776

10.1097/hep.0000000000000720 | PMID 38088872 Get It

Occurrence of metabolic dysfunction–associated steatotic liver disease (MASLD) is common following liver transplantation (LT). MASLD can be classified as a recurrent disease when it occurs in patients receiving LT for metabolic dysfunction–associated steatohepatitis (MASH) or as de novo when it occurs in patients undergoing transplantation for non-metabolic dysfunction–associated steatohepatitis etiologies of liver disease. Fibrosis progression in patients with MASLD is accelerated, with progression to cirrhosis occurring more rapidly compared with the general (ie, non-LT) population. Moreover, the metabolic burden in LT recipients with MASLD is high and synergizes with liver disease to negatively affect the clinical course. Despite the oversized clinical burden of MASLD among LT recipients, there is currently a lack of regulatory approach and pathway for therapeutics development in this patient population. The present document, thus, provides guidance for therapeutics development that incorporates nuances of transplant care in patients with post-LT MASLD to facilitate drug development.
Benign Breast Disease and Breast Cancer Risk in the Percutaneous Biopsy Era
Vachon, Celine M. , Carter, Jodi M. , Jensen, Matthew R. , McCauley, Bryan M. , Seymour, Lisa R. , Gehling, Denice, Fischer, Jessica, Ghosh, Karthik, Pacheco-Spann, Laura, Hoskin, Tanya L. , Seymour, Lisa, Radisky, Derek C. , Carter, Jodi , Sherman, Mark E. , Vierkant, Robert A. , Winham, Stacey J. , Vachon, Celine M. , Pacheco-Spann, Laura M. , Degnim, Amy C.

JAMA Surgery | December 13, 2023 | Volume: 159 | Issue: 2 | Pages: 193

10.1001/jamasurg.2023.6382 | PMID 38091020 Get It

Importance Benign breast disease (BBD) comprises approximately 75% of breast biopsy diagnoses. Surgical biopsy specimens diagnosed as nonproliferative (NP), proliferative disease without atypia (PDWA), or atypical hyperplasia (AH) are associated with increasing breast cancer (BC) risk; however, knowledge is limited on risk associated with percutaneously diagnosed BBD. Objectives To estimate BC risk associated with BBD in the percutaneous biopsy era irrespective of surgical biopsy. Design, Setting, and Participants In this retrospective cohort study, BBD biopsy specimens collected from January 1, 2002, to December 31, 2013, from patients with BBD at Mayo Clinic in Rochester, Minnesota, were reviewed by 2 pathologists masked to outcomes. Women were followed up from 6 months after biopsy until censoring, BC diagnosis, or December 31, 2021. Exposure Benign breast disease classification and multiplicity by pathology panel review. Main Outcomes The main outcome was diagnosis of BC overall and stratified as ductal carcinoma in situ (DCIS) or invasive BC. Risk for presence vs absence of BBD lesions was assessed by Cox proportional hazards regression. Risk in patients with BBD compared with female breast cancer incidence rates from the Iowa Surveillance, Epidemiology, and End Results (SEER) program were estimated. Results Among 4819 female participants, median age was 51 years (IQR, 43-62 years). Median follow-up was 10.9 years (IQR, 7.7-14.2 years) for control individuals without BC vs 6.6 years (IQR, 3.7-10.1 years) for patients with BC. Risk was higher in the cohort with BBD than in SEER data: BC overall (standard incidence ratio [SIR], 1.95; 95% CI, 1.76-2.17), invasive BC (SIR, 1.56; 95% CI, 1.37-1.78), and DCIS (SIR, 3.10; 95% CI, 2.54-3.77). The SIRs increased with increasing BBD severity (1.42 [95% CI, 1.19-1.71] for NP, 2.19 [95% CI, 1.88-2.54] for PDWA, and 3.91 [95% CI, 2.97-5.14] for AH), comparable to surgical cohorts with BBD. Risk also increased with increasing lesion multiplicity (SIR: 2.40 [95% CI, 2.06-2.79] for ≥3 foci of NP, 3.72 [95% CI, 2.31-5.99] for ≥3 foci of PDWA, and 5.29 [95% CI, 3.37-8.29] for ≥3 foci of AH). Ten-year BC cumulative incidence was 4.3% for NP, 6.6% for PDWA, and 14.6% for AH vs an expected population cumulative incidence of 2.9%. Conclusions and Relevance In this contemporary cohort study of women diagnosed with BBD in the percutaneous biopsy era, overall risk of BC was increased vs the general population (DCIS and invasive cancer combined), similar to that in historical BBD cohorts. Development and validation of pathologic classifications including both BBD severity and multiplicity may enable improved BC risk stratification.
Trends in Infective Endocarditis Mortality in the United States: 1999 to 2020: A Cause for Alarm
Chobufo, Muchi Ditah , Vasudevan, Archana , Bhandari, Ruchi , Badhwar, Vinay , Baddour, Larry M. , Balla, Sudarshan , Vasudevan, Archana , Bhandari, Ruchi , Badhwar, Vinay , Baddour, Larry , Balla, Sudarshan , Atti, Varunsiri

Journal of the American Heart Association | December 13, 2023 | Volume: 12 | Issue: 24 | Pages: No page available

10.1161/jaha.123.031589 | PMID 38088249 Get It

Background Data on national trends in mortality due to infective endocarditis (IE) in the United States are limited. Methods and Results Utilizing the multiple causes of death data from the Centers for Disease Control and Prevention's Wide‐Ranging Online Data for Epidemiologic Research database from 1999 to 2020, IE and substance use were identified using the International Classification of Diseases, Tenth Revision, Clinical Modification codes. Between 1999 and 2020, the IE‐related age‐adjusted mortality rates declined. IE‐related crude mortality accelerated significantly in the age groups 25–34 years (average annual percentage change, 5.4 [95% CI, 3.1–7.7]; P <0.001) and 35–44 years (average annual percentage change, 2.3 [95% CI, 1.3–3.3]; P <0.001), but remained stagnant in those aged 45–54 years (average annual percentage change, 0.5 [95% CI, −1.9 to 3]; P =0.684), and showed a significant decline in those aged ≥55 years. A concomitant substance use disorder as multiple causes of death in those with IE increased drastically in the 25–44 years age group ( P <0.001). The states of Kentucky, Tennessee, and West Virginia showed an acceleration in age‐adjusted mortality rates in contrast to other states, where there was predominantly a decline or static trend for IE. Conclusions Age‐adjusted mortality rates due to IE in the overall population have declined. The marked acceleration in mortality in the 25‐ to 44‐year age group is a cause for alarm. Regional differences with acceleration in IE mortality rates were noted in Kentucky, Tennessee, and West Virginia. We speculate that this acceleration was likely due mainly to the opioid crisis that has engulfed several states and involved principally younger adults.